Polonovski Reaction

What Is Polonovski Reaction?

The Polonovski reaction is the rearrangement of tertiary amine N-oxides upon treatment with an acylating agent (typically acetic anhydride) to yield N,N-disubstituted amides and aldehydes (or ketones). The reaction proceeds through activation of the N-oxide, followed by fragmentation and rearrangement of one of the N-alkyl substituents. The reaction was first reported in 1927 by the French biochemist Max Polonovski and his brother Michel Polonovski.

The Polonovski reaction has evolved significantly since its discovery. The classical protocol uses acetic anhydride as the activating agent and proceeds via an iminium intermediate. The scope was later expanded with the development of "non-classical" variants employing alternative activating agents, such as iron(II) sulfate, sulfur dioxide, and cyanogen bromide. These modifications have greatly broadened the synthetic utility of the reaction, particularly in the field of alkaloid chemistry, where the Polonovski reaction serves as the primary method for N-demethylation of tertiary amine alkaloids.

• Reagents: Classical: acetic anhydride (Ac₂O); non-classical variants: iron(II) sulfate, cyanogen bromide (BrCN), sulfur dioxide (SO₂), or chloroformate esters.
• Reactants: Tertiary amine N-oxides. At least one of the N-alkyl substituents must contain an α-hydrogen atom for the classical rearrangement to occur.
• Products: N,N-Disubstituted amides, along with an aldehyde or ketone derived from the migrating alkyl group. In the non-classical N-demethylation variant, the product is the corresponding secondary amine.
• Reaction Type: N-Oxide activation-fragmentation-rearrangement; oxidative N-dealkylation.
• Related Reactions: Polonovski-Potier rearrangement (trifluoroacetic anhydride (TFAA)-mediated variant, used in bis-indole alkaloid synthesis); Cope elimination (thermal syn-elimination of amine N-oxides to alkenes); von Braun reaction (cyanogen bromide-mediated N-dealkylation of tertiary amines).
• Experimental Tips: a) N-Oxide preparation: The tertiary amine is oxidized to the N-oxide using hydrogen peroxide (H₂O₂) or m-CPBA prior to the rearrangement. The N-oxide is often used without purification. b) Classical vs. non-classical: The classical Polonovski with Ac₂O requires an α-hydrogen on the migrating alkyl group. The non-classical variant (FeSO₄ or BrCN) is preferred for N-demethylation of alkaloids, as it does not require an α-hydrogen.

Fig 1. Polonovski reaction and its mechanism. [1]

Mechanism of Polonovski Reaction

Classical Pathway (Acetic Anhydride)

The classical Polonovski reaction begins with acylation of the N-oxide oxygen by acetic anhydride to form an N-acetoxyammonium salt. This activated intermediate undergoes deprotonation at the α-position of one of the N-alkyl substituents, generating an iminium ion. Hydrolysis of the iminium ion yields the N,N-disubstituted acetamide and the corresponding aldehyde (or ketone) derived from the migrating alkyl group. The regioselectivity of the fragmentation—i.e., which alkyl group migrates—is governed by the relative acidity of the α-protons on the different N-substituents.

Non-Classical (Modified) Pathway

Several non-classical variants of the Polonovski reaction have been developed to address the limitations of the original protocol. The use of iron(II) sulfate as the activating agent, for example, generates an N-oxide-Fe(II) complex that undergoes homolytic cleavage to produce an iminium radical cation, which can fragment to give the secondary amine (after hydrolysis) and formaldehyde. This pathway is particularly useful for N-demethylation of alkaloids bearing a methyl group on the tertiary amine nitrogen. The cyanogen bromide (von Braun-type) and chloroformate ester variants operate through distinct mechanistic pathways that also lead to N-dealkylation, providing complementary selectivity profiles. [2]

Application Examples of Polonovski Reaction

• N-Demethylation of Opiate Alkaloids: The non-classical Polonovski reaction has become the method of choice for N-demethylation of opiate alkaloids such as morphine, codeine, and thebaine. This transformation is of critical importance because the N-demethylated products (normorphine, norcodeine, etc.) serve as key intermediates for the synthesis of important opioid antagonists and semi-synthetic analgesics, including naloxone, naltrexone, and nalbuphine. Antonio M. Ruda and colleagues developed and scaled up an environmentally friendly, iron-catalyzed non-classical Polonovski reaction, successfully achieving the N-demethylation of MCL-509 Methyl to the secondary amine MCL-509 Amine·HCl; both compounds are key intermediates in the synthesis of MCL-509, a potential therapeutic agent for Parkinson's disease. [3]
• Tropane Alkaloid Chemistry: The Polonovski reaction has been applied to the N-demethylation of tropane alkaloids such as atropine and scopolamine. The resulting nortropane derivatives are valuable synthetic intermediates for the preparation of structurally diverse tropane-based pharmaceuticals.
• Synthesis of Galanthamine Derivatives: The Polonovski reaction has been employed in the synthesis of galanthamine derivatives, a class of Amaryllidaceae alkaloids used in the treatment of Alzheimer's disease. The N-demethylation step is critical for accessing the pharmacologically active norgalanthamine core.

Fig 2. Synthetic examples via Polonovski reaction. [3,4]

Related Products

CAS No.	Structure	Product
1184-78-7		Trimethylamine N-oxide
1643-20-5		Ldao
2605-79-0		1-Decanamine,N,N-dimethyl-,N-oxide
62637-93-8		Trimethylamine N-oxide dihydrate
70187-32-5		4-Methylmorpholine N-oxide monohydrate
7529-22-8		4-Methylmorpholine N-oxide
120013-84-5		Rac(cis/trans)donepezil N-oxide
1076199-41-1		Ropinirole N-oxide
108332-76-9		Medifoxamine N-oxide
13103-04-3		Tri-N-octylamine-N-oxide
15178-71-9		N,N-Dimethylundecylamine N-oxide
171367-22-9		Metoclopramide N-oxide

References

1. Jie Jack Li. Name Reactions-A Collection of Detailed Mechanisms and Synthetic Applications, Sixth Edition, 2021, 452-454.
2. Singh, Gurmit, et al. Bioorganic & medicinal chemistry letters 22.6 (2012): 2160-2162.
3. Ruda, Antonio M., et al. Organic Process Research & Development 26.5 (2022): 1398-1404.
4. Dehury, Bhabani Sankar, et al. Organic Letters 26.50 (2024): 10690-10695.

Please kindly note that our products are for research use only.